PR
|
|
|
|
|
||||
|---|---|---|---|---|---|---|---|
| 50,491.87 | -536.55 | 155.34 | +0.21 | 47,954.99 | +104.05 | 3,902.80 | +27.01 |
| -1.05% | 0.14% | 0.21% | 0.70% | ||||
開示 |
Determination of Target Disease for mRNA-Targeted Nucleic Acid Drug for In-house Pipeline![]() |
|
開示 |
mRNA標的核酸医薬自社パイプラインの対象疾患決定のお知らせ![]() |